Clinical trials
Cataract trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
220 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 11 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 11 |
| 2017 | 8 |
| 2018 | 20 |
| 2019 | 21 |
| 2020 | 18 |
| 2021 | 22 |
| 2022 | 30 |
| 2023 | 20 |
| 2024 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 220 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vienna Institute for Research in Ocular Surgery | 17 |
| Prim. Prof. Dr. Oliver Findl, MBA | 11 |
| Sun Yat-sen University | 8 |
| Wenzhou Medical University | 8 |
| Guy's and St Thomas' NHS Foundation Trust | 5 |
| Uptown Eye Specialists | 4 |
| AST Products, Inc. | 3 |
| Aier School of Ophthalmology, Central South University | 3 |
| Assiut University | 3 |
| Eye & ENT Hospital of Fudan University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cataract | 220 |
| Astigmatism | 18 |
| Glaucoma | 12 |
| Presbyopia | 8 |
| Dry Eye Syndromes | 6 |
| Pseudophakia | 6 |
| Eye Diseases | 5 |
| Corneal Diseases | 4 |
| Diabetic Retinopathy | 4 |
| Glaucoma, Open-Angle | 4 |
Trials
Showing 26 to 50 of 220. Each trial links to its page on Pharma Observatory.
120 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.